Micro insulin pump for mobile diabetes management

The Cellnovo system is the world’s first mobile diabetes management system, including an insulin patch pump, activity monitor, cellular-enabled wireless touchscreen handset with integrated blood glucose meter and automatic connectivity.

The system allows optimal management of insulin injections whilst ensuring extensive freedom of movement for Type 1 diabetes patients. The system has CE mark, and is on the market in the United Kingdom and several European countries.

CEO  Sophie Baratte

Advent Contact  Raj Parekh

Advent invested in the Series A in 2008. Cellnovo listed on Euronext in July 2015 (EPA:CLNV).
Exited Investments
9 July 2015 in Cellnovo, Press Release

Success of Cellnovo’s IPO with €31.6 million raised on Euronext in Paris

Press Release.   Offer price set at €10.63 per share Market capitalization of €113.6 million Funds to develop production capabilities and accelerate commercial expansion Paris, France, July 9, 2015 –…
Read More
5 February 2014 in Cellnovo, Press Release

Cellnovo launches first Mobile Diabetes Management System at the ATTD Conference in Vienna, Austria

Press Release.   Real-time tracking - an industry first for insulin pump technology Swansea, 5 February 2014 – Cellnovo, the leading innovator in Mobile Diabetes Management technology, today announces the…
Read More
9 February 2012 in Cellnovo, Press Release

Cellnovo launches world’s first mobile-connected diabetes management system

Press Release.   LONDON UK/BARCELONA, SPAIN – February 9, 2012 – Cellnovo today announced both the launch of the world’s only mobile-connected diabetes management system, and the start of the…
Read More
18 October 2011 in Cellnovo, Press Release

Cellnovo receives 2011 Best MedTech Fundraiser Award

Press Release.   LONDON, UK – October 18, 2011 – Cellnovo was named Best Medtech Fundraiser at the recent 2011 OBN Bioscience Awards, an honour that recognises Cellnovo’s success in…
Read More